Published on 5/25/2006 in the Prospect News Biotech Daily.
Agile closes $12 million round of equity financing
By Lisa Kerner
Erie, Pa., May 25 - Agile Therapeutics, Inc. closed a $12 million round of equity financing.
Proceeds will be used to further the development of the company's low-dose transdermal contraceptive patch.
The investment was led by new investor ProQuest Investments, joined by previous investors including the Hillman Co., TL Ventures and PA Early Stage Partners, and current investors.
Located in West Conshohocken, Pa., Agile specializes in proprietary transdermal drug delivery technology.
| Issuer: | Agile Therapeutics, Inc.
|
| Issue: | Equity financing
|
| Amount: | $12 million
|
| Investors: | ProQuest Investments (lead), Hillman Co., TL Ventures, PA Early Stage Partners, current investors
|
| Announcement date: | May 25
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
